Fosså SD - Search Results

1

C-reactive protein; a potential marker of second cancer and cardiovascular disease in testicular cancer survivors?

Wethal T, Haugnes HS, Kjekshus J, Småstuen MC, Ueland T, Aukrust P, Fosså SD. Wethal T, et al. Among authors: fossa sd. Eur J Cancer. 2010 Dec;46(18):3425-33. doi: 10.1016/j.ejca.2010.08.004. Epub 2010 Sep 9. Eur J Cancer. 2010. PMID: 20832295

2

Psychosocial well-being in testicular cancer patients.

Kaasa S, Aass N, Mastekaasa A, Lund E, Fosså SD. Kaasa S, et al. Among authors: fossa sd. Eur J Cancer. 1991;27(9):1091-5. doi: 10.1016/0277-5379(91)90299-s. Eur J Cancer. 1991. PMID: 1683558

3

Prediction of long-term gonadal toxicity after standard treatment for testicular cancer.

Aass N, Fosså SD, Theodorsen L, Norman N. Aass N, et al. Among authors: fossa sd. Eur J Cancer. 1991;27(9):1087-91. doi: 10.1016/0277-5379(91)90298-r. Eur J Cancer. 1991. PMID: 1720322

4

Second non-germ cell malignancies after radiotherapy of testicular cancer with or without chemotherapy.

Fosså SD, Langmark F, Aass N, Andersen A, Lothe R, Børresen AL. Fosså SD, et al. Br J Cancer. 1990 Apr;61(4):639-43. doi: 10.1038/bjc.1990.142. Br J Cancer. 1990. PMID: 2109999 Free PMC article.

5

How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources?

Fosså SD, Jacobsen AB, Aass N, Heilo A, Stenwig AE, Kummen O, Johannessen NB, Waaler G, Ogreid P, Borge L, et al. Fosså SD, et al. Br J Cancer. 1994 Dec;70(6):1156-60. doi: 10.1038/bjc.1994.464. Br J Cancer. 1994. PMID: 7981068 Free PMC article.

6

Trends in incidence of testicular cancer in Norway 1955-1992.

Wanderås EH, Tretli S, Fosså SD. Wanderås EH, et al. Among authors: fossa sd. Eur J Cancer. 1995 Nov;31A(12):2044-8. doi: 10.1016/0959-8049(95)00321-5. Eur J Cancer. 1995. PMID: 8562163

7

Risk of cancer in relatives of testicular cancer patients.

Heimdal K, Olsson H, Tretli S, Flodgren P, Børresen AL, Fossa SD. Heimdal K, et al. Among authors: fossa sd. Br J Cancer. 1996 Apr;73(7):970-3. doi: 10.1038/bjc.1996.174. Br J Cancer. 1996. PMID: 8611417 Free PMC article.

8

Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients.

Wanderås EH, Fosså SD, Tretli S. Wanderås EH, et al. Among authors: fossa sd. Eur J Cancer. 1997 Feb;33(2):244-52. doi: 10.1016/s0959-8049(96)00459-5. Eur J Cancer. 1997. PMID: 9135496

9

Risk of subsequent non-germ cell cancer after treatment of germ cell cancer in 2006 Norwegian male patients.

Wanderås EH, Fosså SD, Tretli S. Wanderås EH, et al. Among authors: fossa sd. Eur J Cancer. 1997 Feb;33(2):253-62. doi: 10.1016/s0959-8049(96)00458-3. Eur J Cancer. 1997. PMID: 9135497

10

Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy.

Fosså SD, Oliver RT, Stenning SP, Horwich A, Wilkinson P, Read G, Mead GM, Roberts JT, Rustin G, Cullen MH, Kaye SB, Harland SJ, Cook P. Fosså SD, et al. Eur J Cancer. 1997 Aug;33(9):1380-7. doi: 10.1016/s0959-8049(96)00425-x. Eur J Cancer. 1997. PMID: 9337678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

936 results

Search Page

Filters